Literature DB >> 14725462

Preparation and characterization of new chiral nitronyl nitroxides bearing a stereogenic center in the imidazolyl framework.

Satoshi Shimono1, Rui Tamura, Naohiko Ikuma, Tatsuya Takimoto, Naoyuki Kawame, Osamu Tamada, Naoko Sakai, Hiroaki Matsuura, Jun Yamauchi.   

Abstract

A synthetic procedure for optically active and racemic alpha-nitronyl nitroxides (alpha-NNs) having a stereogenic center at the 4-position of the imidazolyl ring is described. This procedure consists of (1) the synthesis of a dissymmetric vic-dinitro compound by Kornblum reaction, (2) the enantiomeric resolution of the racemate by a diastereomer method for obtaining the optically active sample, (3) the quick reduction of the optically active or racemic vic-dinitro compound to the bis(hydroxyamino) derivative with Al/Hg, (4) the solvent-free condensation of the bis(hydroxyamino) compound with an aldehyde to give the 1,3-dihydroxyimidazolidine, and (5) the final oxidation of the alpha-NN precursor with aqueous NaIO(4). The absolute configuration of the optically active alpha-NNs was assigned by correlating with the X-ray crystal structure of the (-)-(1S,4R)-camphanic acid ester derivative of the optically active vic-dinitro compound. The molecular conformation of the optically active alpha-NNs was found to be folded both in solution and in the solid state by CD spectroscopy and energy minimization with the Monte Carlo method. The magnetic properties of both optically active and racemic alpha-NNs in solution and in the solid state were characterized by EPR spectroscopy and magnetic susceptibility measurement, respectively.

Entities:  

Year:  2004        PMID: 14725462     DOI: 10.1021/jo0354443

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  2 in total

1.  1,3-Alternate calix[4]arene nitronyl nitroxide tetraradical and diradical: synthesis, X-ray crystallography, paramagnetic NMR spectroscopy, EPR spectroscopy, and magnetic studies.

Authors:  Andrzej Rajca; Maren Pink; Sumit Mukherjee; Suchada Rajca; Kausik Das
Journal:  Tetrahedron       Date:  2007-10-29       Impact factor: 2.457

2.  (R)-2-[1-(2,6-Dichloro-3,4,5-trimeth-oxy-benzo-yl)pyrrolidin-2-yl]-4,4,5,5-tetra-methyl-4,5-dihydro-1H-imidazole-1-oxyl 3-oxide.

Authors:  Hai-Bo Wang; Zhuo Xiang; Lin-Lin Jing; Min Tian; Xiao-Li Sun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-03-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.